1-3 of 3
Ana Limon
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Iadademstat and Gilteritinib for the Treatment of FLT3-Mutated Relapsed/Refractory Acute Myeloid Leukemia: The Frida Study

Amir T. Fathi, Theodore P Braun, Alexander Joseph Ambinder, Gautam Borthakur, Robert L. Redner, Mabel Arevalo, Sonia Gutierrez, Ana Limon, Douglas V. Faller
Journal: Blood
Blood (2023) 142 (Supplement 1): 5974.
https://doi.org/10.1182/blood-2023-189291
Published: 2023
Journal Articles

The Frida Study: An Option for Mutated FLT3 Relapsed/Refractory Acute Myeloid Leukemia Patients with a Novel Iadademstat and Gilteritinib Combination Therapy

Amir T. Fathi, Mabel Arevalo, Sonia Gutierrez, Antonieta Molero, Natalia Sacilotto, Ana Limon, Douglas V Faller
Journal: Blood
Blood (2022) 140 (Supplement 1): 11755–11756.
https://doi.org/10.1182/blood-2022-160427
Published: 2022
Journal Articles

Flowing cells through pulsed electric fields efficiently purges stem cell preparations of contaminating myeloma cells while preserving stem cell function

Brief Report
Abie Craiu, Yoriko Saito, Ana Limon, Henry M. Eppich, Douglas P. Olson, Neil Rodrigues, Gregor B. Adams, David Dombkowski, Paul Richardson, Robert Schlossman, Peter S. Choi, Jonathan Grogins, Paula G. O'Connor, Kenneth Cohen, Eyal C. Attar, Jay Freshman, Rebecca Rich, Joseph A. Mangano, John G. Gribben, Kenneth C. Anderson, David T. Scadden
Journal: Blood
Blood (2005) 105 (5): 2235–2238.
https://doi.org/10.1182/blood-2003-12-4399
Published: 2005